Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 1.89
ELGX's Cash to Debt is ranked higher than
69% of the 291 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.74 vs. ELGX: 1.89 )
ELGX' s 10-Year Cash to Debt Range
Min: 1.52   Max: No Debt
Current: 1.89

Equity to Asset 0.41
ELGX's Equity to Asset is ranked higher than
53% of the 285 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.63 vs. ELGX: 0.41 )
ELGX' s 10-Year Equity to Asset Range
Min: 0.41   Max: 0.96
Current: 0.41

0.41
0.96
F-Score: 3
Z-Score: 2.68
M-Score: -3.98
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry
vs
history
Operating margin (%) -7.84
ELGX's Operating margin (%) is ranked higher than
58% of the 287 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.44 vs. ELGX: -7.84 )
ELGX' s 10-Year Operating margin (%) Range
Min: -237.33   Max: -4.47
Current: -7.84

-237.33
-4.47
Net-margin (%) -12.15
ELGX's Net-margin (%) is ranked higher than
58% of the 287 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.65 vs. ELGX: -12.15 )
ELGX' s 10-Year Net-margin (%) Range
Min: -228.8   Max: 15.84
Current: -12.15

-228.8
15.84
ROE (%) -15.36
ELGX's ROE (%) is ranked higher than
57% of the 283 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.68 vs. ELGX: -15.36 )
ELGX' s 10-Year ROE (%) Range
Min: -79.16   Max: 11.34
Current: -15.36

-79.16
11.34
ROA (%) -6.27
ELGX's ROA (%) is ranked higher than
59% of the 290 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.24 vs. ELGX: -6.27 )
ELGX' s 10-Year ROA (%) Range
Min: -67.04   Max: 7.93
Current: -6.27

-67.04
7.93
ROC (Joel Greenblatt) (%) -141.29
ELGX's ROC (Joel Greenblatt) (%) is ranked higher than
52% of the 288 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 22.38 vs. ELGX: -141.29 )
ELGX' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -171550   Max: -19.87
Current: -141.29

-171550
-19.87
Revenue Growth (%) 16.60
ELGX's Revenue Growth (%) is ranked higher than
90% of the 248 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.70 vs. ELGX: 16.60 )
ELGX' s 10-Year Revenue Growth (%) Range
Min: -41.8   Max: 66.8
Current: 16.6

-41.8
66.8
EBITDA Growth (%) 73.80
ELGX's EBITDA Growth (%) is ranked higher than
97% of the 210 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.40 vs. ELGX: 73.80 )
ELGX' s 10-Year EBITDA Growth (%) Range
Min: -50   Max: 73.8
Current: 73.8

-50
73.8
» ELGX's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2013

ELGX Guru Trades in Q1 2013

Ron Baron 1,288,000 sh (unchged)
Steven Cohen 198,900 sh (-3.21%)
Pioneer Investments 282,100 sh (-19.1%)
» More
Q2 2013

ELGX Guru Trades in Q2 2013

Steven Cohen 913,658 sh (+359.36%)
Pioneer Investments 481,700 sh (+70.76%)
Ron Baron 1,288,000 sh (unchged)
» More
Q3 2013

ELGX Guru Trades in Q3 2013

Ron Baron 1,288,000 sh (unchged)
Pioneer Investments 447,900 sh (-7.02%)
Steven Cohen 550,165 sh (-39.78%)
» More
Q4 2013

ELGX Guru Trades in Q4 2013

Jim Simons 11,100 sh (New)
Ron Baron 1,288,000 sh (unchged)
Pioneer Investments 394,200 sh (-11.99%)
Steven Cohen 333,802 sh (-39.33%)
» More
» Details

Insider Trades

Latest Guru Trades with ELGX

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Ron Baron 2012-09-30 Add 71.73%0.05%$11.15 - $15.54 $ 12.43-7%1288000
Ron Baron 2012-06-30 New Buy0.07%$13.21 - $15.27 $ 12.43-12%750000
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 7.60
ELGX's P/B is ranked lower than
69% of the 278 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.77 vs. ELGX: 7.60 )
ELGX' s 10-Year P/B Range
Min: 1.69   Max: 14.14
Current: 7.6

1.69
14.14
P/S 5.90
ELGX's P/S is ranked lower than
74% of the 292 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.60 vs. ELGX: 5.90 )
ELGX' s 10-Year P/S Range
Min: 1.14   Max: 53.43
Current: 5.9

1.14
53.43
EV-to-EBIT 0.50
ELGX's EV-to-EBIT is ranked higher than
98% of the 247 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 18.32 vs. ELGX: 0.50 )
ELGX' s 10-Year EV-to-EBIT Range
Min: 0.6   Max: 13.6
Current: 0.5

0.6
13.6

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 207.20
ELGX's Price/Net Current Asset Value is ranked lower than
96% of the 118 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 13.00 vs. ELGX: 207.20 )
ELGX' s 10-Year Price/Net Current Asset Value Range
Min: 1.17   Max: 1424
Current: 207.2

1.17
1424
Price/Tangible Book 24.40
ELGX's Price/Tangible Book is ranked lower than
90% of the 232 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.80 vs. ELGX: 24.40 )
ELGX' s 10-Year Price/Tangible Book Range
Min: 1   Max: 114.8
Current: 24.4

1
114.8
Price/Median PS Value 0.70
ELGX's Price/Median PS Value is ranked higher than
85% of the 268 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.10 vs. ELGX: 0.70 )
ELGX' s 10-Year Price/Median PS Value Range
Min: 0.17   Max: 5.96
Current: 0.7

0.17
5.96
Earnings Yield (Greenblatt) 209.80
ELGX's Earnings Yield (Greenblatt) is ranked higher than
97% of the 226 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.40 vs. ELGX: 209.80 )
ELGX' s 10-Year Earnings Yield (Greenblatt) Range
Min: 7.4   Max: 218.8
Current: 209.8

7.4
218.8
Forward Rate of Return (Yacktman) -1.24
ELGX's Forward Rate of Return (Yacktman) is ranked higher than
68% of the 217 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.90 vs. ELGX: -1.24 )
ELGX' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 43.9   Max: 385.4
Current: -1.24

43.9
385.4

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Traded in other countries:RM1.Germany
Endologix, Inc., was incorporated in California in March 1992 under the name Cardiovascular Dynamics, Inc. and reincorporated in Delaware in June 1993. The Company develops, manufactures, markets and sells innovative treatments for aortic disorders. Its main product is a stent graft and delivery system, for the treatment of abdominal aortic aneurysms ('AAA') through minimally-invasive endovascular repair ('EVAR'). Sales of its ELG System to hospitals in the U.S., and to hospitals and third-party distributors abroad, provide the sole source of its reported revenue. Its ELG System consists of a self-expanding cobalt chromium alloy stent covered by expanded polytetrafluoroethylene graft material; and an accompanying delivery catheter. Once its ELG Device is fixed in its proper position within the abdominal aorta, it provides a conduit for blood flow, thereby relieving pressure within the weakened or 'aneurysmal' section of the vessel wall, which greatly reduces the potential for the AAA to rupture. The Company's ELG System consists of its ELG Device and catheter delivery system, branded under the names AFX, IntuiTrak, and Powerlink. All of its products are manufactured, assembled, packaged and sterilized at its 60,000 square foot leased facility in Irvine, California. It market and sell its ELG System in the U.S. and in several European countries through a direct sales force and network of agents. In certain other European countries and in Asia, South America, and Mexico, it sells its ELG System through exclusive independent distributors. Its main competitors include Medtronic Inc., W.L. Gore Inc., and Cook Medical Products, Inc., Terumo-Vascutek, Trivascular, Aptus, Altura, Cordis, Jotec, Bolton, and Lombard Medical. The Company is subject to other federal, state and local laws, regulations and recommendations relating to safe working conditions, laboratory and manufacturing practices.

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide